Erin Wright
Stock Analyst at Morgan Stanley
(2.93)
# 1,361
Out of 5,173 analysts
255
Total ratings
70%
Success rate
27.44%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOH Molina Healthcare | Maintains: Equal-Weight | $158 → $128 | $135.24 | -5.35% | 4 | Mar 4, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $40 → $48 | $42.10 | +14.01% | 5 | Mar 4, 2026 | |
| HSIC Henry Schein | Maintains: Underweight | $58 → $61 | $74.46 | -18.08% | 6 | Feb 25, 2026 | |
| ELAN Elanco Animal Health | Maintains: Equal-Weight | $22 → $24 | $24.44 | -1.80% | 13 | Feb 25, 2026 | |
| PSX Phillips 66 | Maintains: Equal-Weight | $140 → $147 | $176.76 | -16.84% | 3 | Feb 5, 2026 | |
| ALGN Align Technology | Maintains: Equal-Weight | $154 → $169 | $180.86 | -6.56% | 26 | Feb 5, 2026 | |
| HUM Humana | Downgrades: Underweight | $262 → $174 | $170.14 | +2.27% | 6 | Feb 2, 2026 | |
| COR Cencora | Upgrades: Overweight | $361 → $400 | $320.61 | +24.76% | 2 | Jan 29, 2026 | |
| CAH Cardinal Health | Maintains: Overweight | $224 → $245 | $206.40 | +18.70% | 13 | Jan 29, 2026 | |
| OPCH Option Care Health | Maintains: Overweight | $35 → $38 | $28.41 | +33.76% | 2 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $359 → $352 | $289.24 | +21.70% | 5 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $89 → $93 | $71.29 | +30.45% | 7 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $211 → $175 | $115.23 | +51.87% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $857 → $916 | $877.01 | +4.45% | 10 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $765 → $805 | $578.51 | +39.15% | 19 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $25.82 | -34.16% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $53.80 | -51.67% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $261.49 | +49.15% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $2.32 | +38.10% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.54 | +99.31% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $195.60 | -12.07% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $269.54 | +117.78% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $264.42 | +13.46% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $7.59 | +453.36% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $190.00 | +51.58% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $158.00 | +122.78% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.07 | +1,333.22% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $456.93 | -60.39% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $75.73 | -77.55% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $23.59 | +412.93% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $478.12 | +21.31% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $6.35 | +451.18% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $100.35 | +104.29% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $16.33 | -32.64% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $166.96 | -5.97% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $616.25 | -50.02% | 1 | Oct 25, 2017 |
Molina Healthcare
Mar 4, 2026
Maintains: Equal-Weight
Price Target: $158 → $128
Current: $135.24
Upside: -5.35%
BrightSpring Health Services
Mar 4, 2026
Maintains: Overweight
Price Target: $40 → $48
Current: $42.10
Upside: +14.01%
Henry Schein
Feb 25, 2026
Maintains: Underweight
Price Target: $58 → $61
Current: $74.46
Upside: -18.08%
Elanco Animal Health
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $22 → $24
Current: $24.44
Upside: -1.80%
Phillips 66
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $140 → $147
Current: $176.76
Upside: -16.84%
Align Technology
Feb 5, 2026
Maintains: Equal-Weight
Price Target: $154 → $169
Current: $180.86
Upside: -6.56%
Humana
Feb 2, 2026
Downgrades: Underweight
Price Target: $262 → $174
Current: $170.14
Upside: +2.27%
Cencora
Jan 29, 2026
Upgrades: Overweight
Price Target: $361 → $400
Current: $320.61
Upside: +24.76%
Cardinal Health
Jan 29, 2026
Maintains: Overweight
Price Target: $224 → $245
Current: $206.40
Upside: +18.70%
Option Care Health
Jan 13, 2026
Maintains: Overweight
Price Target: $35 → $38
Current: $28.41
Upside: +33.76%
Dec 18, 2025
Maintains: Equal-Weight
Price Target: $359 → $352
Current: $289.24
Upside: +21.70%
Dec 10, 2025
Maintains: Overweight
Price Target: $89 → $93
Current: $71.29
Upside: +30.45%
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $115.23
Upside: +51.87%
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $877.01
Upside: +4.45%
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $578.51
Upside: +39.15%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $25.82
Upside: -34.16%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $53.80
Upside: -51.67%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $261.49
Upside: +49.15%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $2.32
Upside: +38.10%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.54
Upside: +99.31%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $195.60
Upside: -12.07%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $269.54
Upside: +117.78%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $264.42
Upside: +13.46%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $7.59
Upside: +453.36%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $190.00
Upside: +51.58%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $158.00
Upside: +122.78%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.07
Upside: +1,333.22%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $456.93
Upside: -60.39%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $75.73
Upside: -77.55%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $23.59
Upside: +412.93%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $478.12
Upside: +21.31%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $6.35
Upside: +451.18%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $100.35
Upside: +104.29%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $16.33
Upside: -32.64%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $166.96
Upside: -5.97%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $616.25
Upside: -50.02%